Has Rachael Venn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,161 in general payments to Rachael Venn, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachael Venn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachael Venn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachael Venn, MD

Clinical Cardiac Electrophysiology · Naples, FLNPI 1457702367

Payments from drug & device makers

$28,161in general payments, 2019–2025

Across 36 payments — averaging $782.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$14K
Medtronic$9K
Boston Scientific$5K
Biosense Webster, Inc.$254
Astellas Pharma US Inc$174
Baxter Healthcare$143
plus $42 from 3 others

What the payments were for

Grants$26,25093%
Food & beverage$1,3595%
Education$5522%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	6	$13,627
Medtronic	14	$8,676
Boston Scientific	5	$5,245
Biosense Webster, Inc.	5	$254
Astellas Pharma US Inc	2	$174
Baxter Healthcare	1	$143
Bridgebio Pharma, Inc.	1	$22
Scpharmaceuticals Inc.	1	$14
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,161 in reported general payments places this provider in the 40th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida →

Medicare billing

Part B allowed, 2024

$34,044

Medicare patients

140

Services billed

298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	11	$9,576
Metoprolol Succinate	17	$267

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Naples

Dinesh SharmaNaples$665K
Kenneth PlunkittNaples$282K
Jose Osorio FilhoMiami$16.4M
Saumil OzaJacksonville$4.1M
Usman SiddiquiWinter Park$3.6M
David KenigsbergFort Lauderdale$1.3M
Venkata SagiJacksonville$1.2M
Raul WeissMiami Beach$1.1M
Robert FishelAtlantis$1.1M
Naushad ShaikKissimmee$1.1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →